For all patients with BOS antitussives are excluded.
• Appointment of combined preparations containing ephedrine
(Solutan, Broncholytin) is possible only in rare cases of
overproduction of abundant liquid bronchial secretion, as
ephedrine has an expressed "drying" effect.
• At expressed secretion, mucoregulatory products based on
carbocisteine (Broncatar, Mucodyne, Mucopront) can be used.
• Thus, the program of expectorative and mucolytic
therapy is made individually according to clinical
course of the disease in each patient and should
help to restore a patient’s adequate mucociliary
clearance.
Antihistamines
• The use of antihistamines is indicated only at the occurrence or
at worsening of any allergic reactions.
• Second-generation drugs having no effect on the viscosity of
sputum are favored. Beginning from 6 months of age
Ceterizinum ("Zyrtec") is allowed by 0.25 mg / kg 1-2 times
per day.
• For children over 2 years old, Loratadinum ("Claritine"),
Desloratadinum ("Aerius") can be prescribed, over 5 -
Fexofenadinum ("Telfast").
Bronchodilator therapy
•
Short-acting
β
2- agonists are used (Salbutamol, Fenoterolum) - drugs of choice.
•
Preparations are highly selective and therefore have few side effects.
•
Bronchodilator effect at inhalation use occurs within 5-10 minutes.
•
A single dose of Salbutamol is 100-200mkg (1-2 doses), via a nebulizer a single
dose may be considerably higher and is 2.5 mg (nebula by 2,5ml 0.1% solution).
Administered by 3-4 times a day.
•
In severe course of BOS torpid to treatment, as a "first aid treatment“, the
introduction of three inhalations of short-acting
β
2- agonists for one hour with an
interval of 20 minutes is possible.
|
